Are GLP-1 Receptor Agonists Reshaping the Management of Idiopathic Intracranial Hypertension and CSF Leaks?
7th March, 2026, 08:35 - 09:35
Pacific C

Glucagon-Like Peptide-1 (GLP-1) receptor agonists play a key role in managing intracranial hypertension and cerebrospinal fluid leaks by regulating intracranial pressure and promoting weight loss. This session focuses on understanding their pharmacological effects on weight and intracranial pressure and impact on perioperative outcomes in the treatment of idiopathic intracranial hypertension and cerebrospinal fluid leak (CSF) outcomes.

Objectives

At the conclusion of this session, attendees will be able to:

• Understand the pharmacological effects of GLP-1 receptor agonists on intracranial pressure regulation and their therapeutic potential in cerebrospinal fluid leak management.
• Identify how GLP-1 receptor agonists contribute to the treatment of idiopathic intracranial hypertension through metabolic and weight loss mechanisms.
• Evaluate the clinical evidence supporting GLP-1 receptor agonists as a treatment option for obesity-related complications, particularly temporal bone encephaloceles and CSF leaks.

Current Schedule

As a faculty member of this session, you can click on names to email the speaker. Phone numbers are below names